Catalyst

Slingshot members are tracking this event:

Phase 2 36-month OLE data of Patisiran in hATTR Patients with Polyneuropathy expected in late 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ALNY Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 26, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 2, Patisiran, Polyneuropathy